Review: low-grade gliomas as neurodevelopmental disorders: insights from mouse models of neurofibromatosis-1. (Q37950470)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22035280%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Review: low-grade gliomas as neurodevelopmental disorders: insights from mouse models of neurofibromatosis-1 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22035280%20AND%20SRC:MED&resulttype=core&format=json

neurodevelopmental disorder

15 January 2020

main subject

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22035280%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

M Thangarajh

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22035280%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

1 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22035280%20AND%20SRC:MED&resulttype=core&format=json

Neuropathology and Applied Neurobiology

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22035280%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22035280%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22035280%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

241-253

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22035280%20AND%20SRC:MED&resulttype=core&format=json

Brain tumor survival: results from the National Cancer Data Base

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Survival and long-term health and cognitive outcomes after low-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Neurocognitive deficits in medulloblastoma survivors and white matter loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Cognitive outcome in pediatric brain tumor survivors: delayed attention deficit at long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Neuropsychological functioning of children treated with intensive chemotherapy followed by myeloablative consolidation chemotherapy and autologous hematopoietic cell rescue for newly diagnosed CNS tumors: an analysis of the Head Start II survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Pediatric low-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

The 2007 WHO classification of tumours of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Spontaneous regression of optic gliomas: thirteen cases documented by serial neuroimaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Cellular proliferation in pilocytic and diffuse astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Mutational and expression analysis of the NF1 gene argues against a role as tumor suppressor in sporadic pilocytic astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

RAS pathway activation and an oncogenic RAS mutation in sporadic pilocytic astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density single-nucleotide polymorphism-based genotype arrays results in a novel BRAF fusion gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Alterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

BRAF-KIAA1549 fusion predicts better clinical outcome in pediatric low-grade astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Constitutive activation of Raf-1 induces glioma formation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Activated BRAF induces gliomas in mice when combined with Ink4a/Arf loss or Akt activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

An activated mutant BRAF kinase domain is sufficient to induce pilocytic astrocytoma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

The neurofibromatosis type 1 gene encodes a protein related to GAP

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Identification of the neurofibromatosis type 1 gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Identification and characterization of the neurofibromatosis type 1 protein product

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Defining the role of mTOR in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Nucleophosmin mediates mammalian target of rapamycin-dependent actin cytoskeleton dynamics and proliferation in neurofibromin-deficient astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Neurofibromin regulates G protein-stimulated adenylyl cyclase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Chemokine action in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Cross-species genomics matches driver mutations and cell compartments to model ependymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Distinct genetic signatures among pilocytic astrocytomas relate to their brain region origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Neurofibromatosis-1 regulates neuroglial progenitor proliferation and glial differentiation in a brain region-specific manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Matrix metalloproteinases: regulators of the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Microglia in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Microglia: active sensor and versatile effector cells in the normal and pathologic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Increased c-Jun-NH2-kinase signaling in neurofibromatosis-1 heterozygous microglia drives microglia activation and promotes optic glioma proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Radiation-induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Preclinical cancer therapy in a mouse model of neurofibromatosis-1 optic glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Optic nerve dysfunction in a mouse model of neurofibromatosis-1 optic glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Ultrastructural characterization of the optic pathway in a mouse model of neurofibromatosis-1 optic glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

Defective cAMP generation underlies the sensitivity of CNS neurons to neurofibromatosis-1 heterozygosity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2011.01230.X

10.1111/J.1365-2990.2011.01230.X

21 January 2018

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tl7lshv4wbcnhlmumjmszqjrxi

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_tl7lshv4wbcnhlmumjmszqjrxi

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tl7lshv4wbcnhlmumjmszqjrxi

mapped directly with Wikidata item

30 July 2022

based on heuristic

https://api.fatcat.wiki/v0/release/tl7lshv4wbcnhlmumjmszqjrxi

1 reference